Skip to main content
Fig. 4 | BMC Gastroenterology

Fig. 4

From: The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials

Fig. 4

The comparison between the vaptans groups and placebo groups about 1-year survival. Studies are identified by the first author’s name and year of publication. The data of intervention groups would be gathered up as one to make the comparison if there are several dose groups comparing with one control group. The Odds Ratios are pooled using the fixed effects model. Abbreviation: CI, confidence interval

Back to article page